Prospects for Moxidectin as a New Oral Treatment for Human Scabies.

The authors discuss the use of moxidectin in treating human scabies. They highlight the addition of scabies to the World Health Organization's list of neglected tropical diseases as well as the Global Burden of Disease study revealing the prevalence of scabies, reportedly among the most common infectious diseases worldwide. They also highlight the limited treatment options available for scabies.